DISTRIBUTION OF STREPTOCOCCUS-PNEUMONIAE RESISTANT TO PENICILLIN IN THE USA AND IN-VITRO SUSCEPTIBILITY TO SELECTED ORAL ANTIBIOTICS

Citation
Eo. Mason et al., DISTRIBUTION OF STREPTOCOCCUS-PNEUMONIAE RESISTANT TO PENICILLIN IN THE USA AND IN-VITRO SUSCEPTIBILITY TO SELECTED ORAL ANTIBIOTICS, Journal of antimicrobial chemotherapy, 36(6), 1995, pp. 1043-1048
Citations number
8
Categorie Soggetti
Microbiology,"Pharmacology & Pharmacy
ISSN journal
03057453
Volume
36
Issue
6
Year of publication
1995
Pages
1043 - 1048
Database
ISI
SICI code
0305-7453(1995)36:6<1043:DOSRTP>2.0.ZU;2-U
Abstract
Surveillance by 33 laboratories in 19 states during a 4 1/2 month peri od between December 1993 and April 1994 found that 263 of 1627 (16.2%) isolates of Streptococcus pneumoniae were resistant to penicillin. On e hundred and seventy (10.4%) isolates were determined to be intermedi ately resistant to penicillin (MICs 0.1-1.0 mg/L and 93 (5.7%) were fo und to be highly resistant to penicillin (MICs > 2.0 mg/L). MIC(90s) f or intermediately penicillin resistant strains were: amoxycillin/clavu lanate 2.0 mg/L, cefaclor 64 mg/L, cefixime 32 mg/L, cefprozil 8 mg/L and loracarbef 128 mg/L. MIC(90s) for highly penicillin resistant stra ins were: amoxycillin/clavulanate 4.0 mg/L, cefaclor greater than or e qual to 128 mg/L cefixime 64 mg/L, cefprozil 32 mg/L and loracarbef gr eater than or equal to 128 mg/L.